Thursday, November 09, 2017 11:20:53 AM
If it was going to crash based on that it would have already. My guess is they don't start selling until the SP is much higher and after the audited 10Q comes out on the 13th. If the audited is anything like the unaudited released today the SP should rise dramatically.
I believe they are raising this capital in anticipation of the Lidocaine Patch FDA approval in February of 2018. They will need to pay for manufacturing and sales channels. If that Lidocaine patch is approved we're talking at least 8.00 to 10.00 per share easy.
Decent volume today and no sell off on the S-3. It's the reason they released the unaudited 10Q before the S-3. So people could digest what looks like a solid 10Q before the S-3.
I could be wrong but just watching L2 looks like people are loading at 2.55.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM